DIVA Laboratories, Ltd., commonly referred to as DIVA, is a leading biotechnology firm headquartered in Taiwan (TW). Established in 2003, the company has made significant strides in the fields of molecular diagnostics and genetic testing, positioning itself as a key player in the healthcare industry. DIVA specialises in innovative solutions for disease detection and management, offering a range of core products that include advanced diagnostic kits and laboratory services. Their unique approach combines cutting-edge technology with a commitment to accuracy and reliability, setting them apart in a competitive market. With a strong presence in Asia and expanding operations globally, DIVA Laboratories has achieved notable milestones, including partnerships with various healthcare institutions. Their dedication to quality and innovation has solidified their reputation as a trusted provider in the biotechnology sector.
How does DIVA Laboratories, Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Communication Equipment Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
DIVA Laboratories, Ltd.'s score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
DIVA Laboratories, Ltd., headquartered in Taiwan (TW), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that DIVA Laboratories may not have established formal commitments to reduce carbon emissions or may be in the early stages of developing such initiatives. In the context of the industry, many organisations are increasingly adopting science-based targets and sustainability commitments to address climate change. However, without specific emissions data or reduction initiatives, it is unclear how DIVA Laboratories aligns with these industry standards. As the company progresses, it may consider implementing strategies to measure and reduce its carbon footprint, thereby contributing to global climate goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
DIVA Laboratories, Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

